methylnitrosourea has been researched along with Cancer, Second Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; McGinley, JN; Thompson, HJ; Zhu, Z | 1 |
| Borges, A; Kothari, A; Kothari, L | 1 |
| Korman, DB | 1 |
3 other study(ies) available for methylnitrosourea and Cancer, Second Primary
| Article | Year |
|---|---|
Adrenalectomy does not block the inhibition of mammary carcinogenesis by dietary energy restriction in rats.
Topics: Adrenalectomy; Animals; Blood Glucose; Body Weight; Caloric Restriction; Female; Hormones; Incidence; Insulin-Like Growth Factor Binding Proteins; Mammary Neoplasms, Experimental; Methylnitrosourea; Neoplasms, Second Primary; Rats; Rats, Sprague-Dawley; Time Factors | 2004 |
Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumours in rats.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Chemoprevention; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Synergism; Estrogen Antagonists; Female; Mammary Neoplasms, Animal; Melatonin; Methylnitrosourea; Neoplasms, Second Primary; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley; Tamoxifen | 1995 |
[The probability of the carcinogenic risk of using nitrosomethylurea for treating cancer patients].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinogens; Follow-Up Studies; Hodgkin Disease; Humans; Male; Methylnitrosourea; Middle Aged; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Probability; Remission Induction; Risk Factors; Time Factors | 2000 |